LMW Banner 2

Your future advertising space? Our media data

Camozzi

Your future advertising space? Our media data

OEM Update

US curb on Indian biopharma firms

August 13, 2009 11:44 am

Indian biopharmaceutical companies are likely to face more hurdles in the US. This is on the back of the US Senate Health, Education, Labour & Pensions Committee approving an amendment that will protect biotech developers from generic competition for 12 years. Though the amendment is yet to be approved by the Congress, if it is passed in its current form, will deal a huge blow to Indian companies engaged in research and manufacture of biosimilar drugs. Biosimilar drugs are similar versions of biotech drugs, akin to generics being copies of chemical drugs.
 

Advertising

Your future advertising space? Our media data

Cookie Consent OEM Update

We use cookies to personalize your experience. By continuing to visit this website you agree to our Terms & Conditions, Privacy Policy and Cookie Policy.

Tags:
Webinar

Your future advertising space? Our media data

Events

Pragyan 24
Mech Auto Expo
India Fastener Show
Aerodef India Manufacturing Expo
ChemPro Tech India
Metal Forming Expo
amtex
Fastener Fair India
Himtex 2024
World of Photonics India

eMagazine February 2024

eMagazine February 2024

Your future advertising space? Our media data

Our Sponsors

Carl Zeiss IndiaCloosSTMCNCPragati GearsNordPurva metalFuji Electric IndiaMaco-cAndreasBibus IndiaInovance TechnologyPMT Machines LtdQuaker HoughtonIgus India Pvt LtdWohlhaupter IndiaReishauerWidmaMeusburgerAutonicsDiffusion Engineers LimitedDiamondZiehl AbeggCarelACE Micromatic GroupFuel Instruments  EngineersFenwick and RaviMMC Hardmetal Pvt LtdMPSTata CapitalProstarmWika Instruments India